This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Oakley Capital Investments Valuation

Q: What is the Fair Price of OCIL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

OCIL (£4.86) is trading below our estimate of [[fair value]] (£16.14)

Is OCIL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OCIL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OCIL (£4.86) is trading below our estimate of fair value (£16.14)

Significantly Below Fair Value: OCIL is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OCIL?

Key metric: As OCIL is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for OCIL. This is calculated by dividing OCIL's market cap by their current earnings.
What is OCIL's PE Ratio?
PE Ratio	13.7x
Earnings	UK£62.94m
Market Cap	UK£860.92m

OCIL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	8.6x
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does OCIL's PE Ratio compare to its peers?

The above table shows the PE ratio for OCIL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	12.9x
XPS XPS Pensions Group	12.3x	-14.5%	UK£756.5m
BPCR BioPharma Credit	9.6x	n/a	US$1.1b
FSG Foresight Group Holdings	19.6x	29.0%	UK£517.4m
IPX Impax Asset Management Group	10.1x	2.5%	UK£411.4m
OCIL Oakley Capital Investments	13.7x	n/a	UK£860.9m

Price-To-Earnings vs Peers: OCIL is good value based on its Price-To-Earnings Ratio (13.7x) compared to the peer average (25x).

Price to Earnings Ratio vs Industry

How does OCIL's PE Ratio compare vs other companies in the GB Capital Markets Industry?

4 Companies	Price / Earnings	Estimated Growth	Market Cap
PNIX Phoenix Digital Assets	1.2x	n/a	US$35.25m
IX. i(x) Net Zero	0.1x	n/a	US$8.94m
APQ APQ Global	0.4x	n/a	US$5.78m
MAFL Mineral & Financial Investments	1.9x	n/a	US$4.82m

No more companies available in this PE range

4 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: OCIL is good value based on its Price-To-Earnings Ratio (13.7x) compared to the UK Capital Markets industry average (15.5x).

Price to Earnings Ratio vs Fair Ratio

What is OCIL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OCIL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	13.7x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate OCIL's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst OCIL forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	n/a	UK£6.27 0%	4.2%	UK£6.53	UK£6.00	n/a	2
Nov ’25	n/a	UK£6.27 0%	4.2%	UK£6.53	UK£6.00	n/a	2
Oct ’25	n/a	UK£6.27 0%	4.2%	UK£6.53	UK£6.00	n/a	2
Sep ’25	n/a	UK£6.27 0%	4.2%	UK£6.53	UK£6.00	n/a	2
Aug ’25	n/a	UK£6.27 0%	4.2%	UK£6.53	UK£6.00	n/a	2
Jul ’25	n/a	UK£6.27 0%	4.2%	UK£6.53	UK£6.00	n/a	2
Jun ’25	n/a	UK£6.27 0%	4.2%	UK£6.53	UK£6.00	n/a	2
May ’25	n/a	UK£6.27 0%	4.2%	UK£6.53	UK£6.00	n/a	2
Apr ’25	n/a	UK£6.27 0%	4.2%	UK£6.53	UK£6.00	n/a	2
Mar ’25	n/a	UK£6.27 0%	4.2%	UK£6.53	UK£6.00	n/a	2
Feb ’25	n/a	UK£6.27 0%	4.2%	UK£6.53	UK£6.00	n/a	2
Jan ’25	n/a	UK£6.27 0%	4.2%	UK£6.53	UK£6.00	n/a	2
Dec ’24	UK£4.47	UK£6.27 +40.2%	4.2%	UK£6.53	UK£6.00	n/a	2
Nov ’24	n/a	UK£6.27 0%	4.2%	UK£6.53	UK£6.00	n/a	2
Oct ’24	UK£4.53	UK£6.27 +38.5%	4.2%	UK£6.53	UK£6.00	n/a	2
Sep ’24	UK£4.50	UK£6.27 +39.2%	4.2%	UK£6.53	UK£6.00	n/a	2
Aug ’24	UK£4.47	UK£6.27 +40.2%	4.2%	UK£6.53	UK£6.00	n/a	2

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

HAL Trust

€10.4b

Operates through multi-sectors in Europe, the United States, Canada, Asia, and internationally.

0K9V

€117.10

2.5%

3.8%

Exor

€20.2b

Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.

0RKY

€93.93

0.7%

6.9%

Man Group

UK£2.4b

Man Group Limited is a publicly owned investment manager.

EMGL

UK£2.06

-0.6%

-0.7%